Title:
ＩＧＦＢＰ３及びその使用
Document Type and Number:
Japanese Patent JP6937745
Kind Code:
B2
Abstract:
The present invention relates to an inhibitor of IGFBP3 binding to TMEM219 and uses thereof for the treatment and/or prevention of an intestinal disease in a subject, in particular the treatment and/or prevention of diabetic enteropathy or inflammatory bowel disease.
Inventors:
Francesca Daddio
Paolo Fiorina
Paolo Fiorina
Application Number:
JP2018515354A
Publication Date:
September 22, 2021
Filing Date:
June 06, 2016
Export Citation:
Assignee:
Ospedale San Raffaele Esseelle Elle
International Classes:
A61K38/16; A61K45/00; A61P1/00; A61P1/04; A61P1/12; A61P1/14; A61P43/00; C12Q1/6883; G01N33/53
Domestic Patent References:
| JP11508608A |
Foreign References:
| US20090170133 | ||||
| WO2001087238A2 |
Other References:
Inflammatory Bowel Disease,2011年 月 日,Vol.17, No.1,pp.193-201
Attorney, Agent or Firm:
Yasuhiko Murayama
Shinya Mitsuhiro
Tatsuhiko Abe
Shinya Mitsuhiro
Tatsuhiko Abe